Contributions of Matrix Metalloproteinases to Neural Plasticity, Habituation, Associative Learning and Drug Addiction by Wright, John W. & Harding, Joseph W.
Hindawi Publishing Corporation
Neural Plasticity
Volume 2009, Article ID 579382, 12 pages
doi:10.1155/2009/579382
Review Article
Contributionsof Matrix Metalloproteinases to NeuralPlasticity,
Habituation, Associative Learningand Drug Addiction
John W. Wright1,2,3 and Joseph W. Harding1,2,3
1Department of Psychology, Washington State University, Pullman, WA 99164-4820, USA
2Department of Veterinary and Comparative Anatomy, Pharmacology and Physiology, Washington State University,
Pullman, WA 99164-6520, USA
3Programs in Neuroscience and Biotechnology, Washington State University, Pullman, WA 99164-6520, USA
Correspondence should be addressed to John W. Wright, wrightjw@wsu.edu
Received 31 August 2009; Revised 22 November 2009; Accepted 15 December 2009
Recommended by Leszek Kaczmarek
The premise of this paper is that increased expression of matrix metalloproteinases (MMPs) permits the reconﬁguration of
synaptic connections (i.e., neural plasticity) by degrading cell adhesion molecules (CAMs) designed to provide stability to those
extracellular matrix (ECM) proteins that form scaﬀolding supporting neurons and glia. It is presumed that while these ECM
proteins are weakened, and/or detached, synaptic connections can form resulting in new neural pathways. Tissue inhibitors of
metalloproteinases (TIMPs) are designed to deactivate MMPs permitting the reestablishment of CAMs, thus returning the system
to a reasonably ﬁxed state. This review considers available ﬁndings concerning the roles of MMPs and TIMPs in reorganizing ECM
proteins thus facilitating the neural plasticity underlying long-term potentiation (LTP), habituation, and associative learning. We
conclude with a consideration of the inﬂuence of these phenomena on drug addiction, given that these same processes may be
instrumental in the formation of addiction and subsequent relapse. However, our knowledge concerning the precise spatial and
temporal relationships among the mechanisms of neural plasticity, habituation, associative learning, and memory consolidation
is far from complete and the possibility that these phenomena mediate drug addiction is a new direction of research.
Copyright © 2009 J. W. Wright and J. W. Harding. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1.Introduction
The formation of long lasting memories appears to depend
upon enduring changes in the strength of neurotransmission
thatalterscellularmechanismsthusreconﬁguringneuralcir-
cuitry and communication [1–6]. This review describes the
relationship among extracellular matrix (ECM) molecules,
cell adhesion molecules (CAMs), matrix metalloproteinases
(MMPs), and tissue inhibitors of matrix metalloproteinases
(TIMPs) in making possible the phenomena of long-
term potentiation (LTP), habituation, associative learning
and memory, and perhaps drug addiction. The ECM is
composed of secreted glycoproteins and proteoglycons that
form scaﬀolding to which cells adhere. Within the cen-
tral nervous system this network consists of the proteins
ﬁbronectin,laminin,vitronectin,thrombospondin,tenascin,
andcollagenIV[7–13].Inadditiontoprovidinganetworkof
scaﬀolding the ECM is involved in a wide range of signaling
that inﬂuences cellular proliferation, growth, movement,
synaptic stabilization, and apoptosis. It is now believed that
these ECM molecules assist in maintaining and changing
the synaptic architecture critical to neural plasticity which
is believed to mediate learning and memory. These ﬁndings
were anticipated by Cajal [14] more than a century ago when
he hypothesized that memory storage is dependent upon
alterations in synaptic connections between neurons.
The interaction of cells and ECM molecules is facilitated
by cell adhesion molecules (CAMs). These molecules are cell
surface macromolecules that dictate cell-to-cell and cell-to-
ECM contacts by using the processes of adhesion, migration,
neurite outgrowth, fasciculation, synaptogenesis, and intra-
cellular signaling [8, 15, 16]. The extracellular domain of
CAMs are targets for proteinase activity; while their intracel-
lular domains interact with cytoskeletal proteins. CAMs are2 Neural Plasticity
Table 1: Matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs), and their preferred substrates.
Group Members Abbrev. Substrate
Collagenases
Fibroblast collag. MMP-1 ﬁbrillar collagens
Neutrophil collag. MMP-8 ﬁbrillar collagens
Collagenase-3 MMP-13 ﬁbrillar collagens
Collagenase-4 χCol 4 collagens
Gelatinases Gelatinase A MMP-2 gelatin, elastin ﬁbronectin, types
IV–VI collagens
Gelatinase B MMP-9 gelatin, elastin, ﬁbronectin, types I, IV
&Vc o l l a g e n s
Membrane-type
MT 1-MMP MMP-14
pro-MMP-2, collagens, gelatin, elastin,
casein, ﬁbronectin, vitronectin,
aggrecan
MT 2-MMP MMP-15 pro-MMP-2, collagens, gelatin,
ﬁbronectin, laminin, nidogen, tenascin
MT 3-MMP MMP-16 pro-MMP-2, collagens, gelatin
MT 4-MMP MMP-17 pro-MMP-2, collagens, gelatin
Stromelysins
Stromelysin-1 MMP-3 ﬁbronectin, collagens, laminin,
non-ﬁbrillar
Stromelysin-2 MMP-10 ﬁbronectin, collagens, laminin,
non-ﬁbrillar collagens
Stromelysin-3 MMP-11 gelatin, ﬁbrillar collagens, α1
proteinase inhibitor (serpin)
Macrophage MMP-12 elastin
Metalloelastase
Matrilysin MMP-7
ﬁbronectin, collagens, laminin,
non-ﬁbrillar collagens, aggrecan,
casein, decorin, insulin
Others
Enamelysin MMP-20 amelogenin
Xenopus collag. MMP-18 unknown
? MMP-19 aggrecan, gelatin, tenascin C
XMMP unknown
TIMPs
TIMP-1 all MMPs except MT1-MMP
TIMP-2 all MMPs
TIMP-3 all MMPs
TIMP-4 all MMPs
Adapted from Wright and Harding [23].
functionally categorized into calcium-dependent (integrins
and cadherins) and calcium-independent (immunoglobu-
lins and selectins) proteins. Integrin receptors are widely
distributed dimeric transmembrane proteins with an extra-
cellular portion that interacts with ECM molecules and cell
surface proteins, and an intracellular portion that makes
contact with the actin cytoskeleton via intermediate proteins
such as α-actinin, talin, tensin, and vinculin. Thus, the
binding of a ligand to the integrin receptor results in a
functional link between the ECM and the actin cytoskeleton
which is mediated through these intermediate proteins.
These proteins trigger intracellular signaling pathways that
can initiate changes in cellular shape, motility, growth, gene
regulation, and apoptosis [17, 18]. It appears that integrins
are very important regarding cell-to-ECM substrate adhe-
sion; while cadherins, syndecans, and neural cell adhesion
molecules are primarily involved with cell-to-cell adhesion
[9]. Each of these CAMs appears to contribute to neural
plasticity as related to memory formation. For additional
detailsthereaderisreferredtothefollowingexcellentreviews
concerning ECM molecules and CAMS [7–13].
2. MMPs and TIMPs
MMPs are a family of proteolytic enzymes involved with
the maintenance and restructuring of the ECM [19–21].
At present 25+ MMPs have been identiﬁed under four
major categories: collagenases, gelatinases, membrane-type,
and stromelysins (Table 1). Many MMPs require serine
proteinases, such as plasmin or other MMPs, for activation.
A pro-peptide must be cleaved in order to reveal the catalyticNeural Plasticity 3
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Figure 1: Diagram describing the inﬂuences of PAI-1, tPA/uPA, plasminogen and plasmin upon the conversion of pro-MMPs to active
MMPs.ManyactiveMMPsfunctiontodegradetheECM;whileTIMPsaredesigned todeactivate theMMPsthuspreservingECMmolecules
and connections. Modiﬁed from Wright and Harding [29] (potential contributions in the areas of memory consolidation, reconsolidation,
and retrieval).
domain of the MMP [22]. MMP degradation of the ECM
is tightly controlled and accomplished by three mechanisms:
(1) regulation of gene transcription; (2) regulation of pro-
enzyme activation; and (3) through the presence of TIMPs.
Most MMPs are nonconstituitively expressed; however gene
transcription may occur via stimulation by growth factors,
oncogene products, phorbol esters, as well as cell-to-cell and
cell-to-ECM interactions.
These stimuli typically provoke various transcription
factors including members of the c-Fos and c-Jun proto-
oncogene families, resulting in the formation of homo- and
hetero-dymeric forms of AP-1 transcription factors. Such
activation of MMP genes requires the combined eﬀects
of AP-1 protein and other transcription factors (see [24,
25] for reviews). At the outset MMPs are maintained as
inactive pro-MMP zymogenes and as such the catalytic
zinc atom is bound to the cysteine residue of the pro-
peptide region (Figure 1). Disruption of the cysteine-zinc
bond occurs via activation factors, a “cysteine switch,” that
reveals the catalytic site. This action exposes an intermediate
form of MMP capable of cleaving the pro-peptide region
via autocatalysis yielding full enzymatic activity [26]. MMP
activation factors include kallikrein, plasmin, thrombin, and
the tissue-type (tPA) and urokinase-type (uPA) plasminogen
activators, plus other MMPs [27, 28].
It is also the case that MMPs can activate other MMPs.
For example, MMP-2, MMP-3, and membrane-type MMPs
(MT-MMPs) activate MMP-1 and MMP-9, while MT-
MMPs can be activated by inhibitory pro-peptide removal,
speciﬁcallyaccomplishedbyfurin,alsoaserineprotease[22].
Such characteristics of MMPs make them attractive concern-
ing their potential contribution to memory consolidation,
reconsolidation,andretrieval.MMP-2,MMP-3,andMMP-9
reach measurable levels in the mammalian brain especially if
the animal is challenged with a change in its environment
(e.g., handling, learning tasks, lesioning, seizure). These
MMPs are also elevated in several pathologies [30, 31]
including Alzheimer’s disease [22, 32–35], and multiple
sclerosis [22, 36–40]. There is accumulating evidence that
MMPs are essential for tumor metastasis, and cell invasion
[9,19,24,41,42].MMPsarealsoactivatedduringstress[43],
brain trauma, and ischemia [22, 44–47]. For a thoughtful
andinformativereviewconcerningthepotentialuseofMMP
inhibitors to treat neurodegenerative diseases see Rosenberg
[48].
As mentioned above, MMPs are involved in axon exten-
sion,andthecontrolofaxonguidanceofreceptorsonthecell
surface via regulated catalysis of ectodomain shedding [49].
Along these lines, the secretion of MMPs by the growth cone
appears to result in the laying down of a pathway through
the ECM [50]. MMPs are also involved in the myelination of
axons in both central and peripheral nervous systems during
development and following damage from injury or disease
[42]. As with neurons, oligodendrocytes secrete MMPs at
the distal cell process [51]. It appears that these MMPs are
also involved in clearing a path through ECM molecules
permitting the growing glial tip to extend. MMP-9 and -12
null mice exhibit retarded myelination and the number of
mature oligodendrocytes is reduced [52]. Increases in MMP-
9 expression have been correlated with myelination of the
mouse corpus callosum during postnatal development [53].
Tissue inhibitors of metalloproteinases 1-4 (TIMP-1-
4) make up a family of secreted glycoproteins (Table 1)
[54]. TIMPs inhibit the proteolytic activities of MMPs via
the formation of tight noncovalent complexes with them
[55, 56]. TIMPs are two-domain proteins linked by three4 Neural Plasticity
disulﬁde bonds with three disulﬁdes per domain. It appears
that TIMPs bind MMPs at a 1:1 ratio such that when in
balance the expression of TIMPs matches that of MMPs
[57]. Thus, the MMP is inhibited by TIMP binding to its
catalytic domain [58]. The disruption of this TIMP/MMP
balance impacts CNS ECM-to-cell and cell-to-cell signaling.
For example, TIMP-1 deﬁcient mice fail to acquire an
odor conditioned learning task, suggesting a dysfunction of
hippocampal neuronal plasticity [59].
Nedivi et al. [60] were ﬁrst to report increased dentate
gyrus levels of TIMP-1 mRNA following seizures. Subse-
quently, elevated TIMP-1 mRNA and protein were measured
in the hippocampus with seizure [61, 62]. Kainate-induced
seizures also elevated MMP-9 mRNA expression and protein
within a few hours [63]. This enhanced MMP-9 mRNA
expressionwasseeninboththedendriticlayersandneuronal
cell bodies primarily within the dentate gyrus. These results
were interpreted to suggest that MMP-9 expression is
involved in activity-dependent remodeling via inﬂuencing
synaptic connections. Shibayama et al. [64], and others
[45, 65], have shown that following mechanical brain injury
MMPs, and particularly TIMPs, are produced by microglia
and astrocytes located in cortex and white matter and may
play a role in neural regeneration (or lack of) depending
upon the degree of expression and the time since injury.
Although our understanding of the mechanism(s)
underlying the functional remodeling of synaptic pathways
remainsincomplete,itisbecomingclearthatsuchreconﬁgu-
ration involves alterations in the levels of MMPs and TIMPs.
3. Categories Of Learning
3.1. Long-Term Potentiation (LTP). Long-term potentia-
tion was originally discovered in the anesthetized rabbit
preparation by Bliss and Lomo [66], and then a similar
electrophysiological approach was used to conﬁrm LTP in
the unanesthetized rabbit [67]. A tetanization electrode was
placed in the perforant path and a recording electrode
was positioned in the dentate area. Excitatory post-synaptic
potentials could be progressively enhanced by short bursts
of electrical stimulation applied via the perforant path
electrode. LTP is now thought to represent a basic physi-
ological mechanism of memory storage [68–71]; however
others suggest that it may represent an arousal/attention
mechanism [72]. Investigators subsequent to Bliss and
colleagues demonstrated that hippocampal LTP is, at least in
part,dependentuponintactN-methyl-D-aspartate(NMDA)
receptors [73–75].
The application of NMDA receptor antagonists has been
shown to prevent LTP and interfere with the successful
performanceofmemorytasksmediatedbythehippocampus
[74, 76–78]; however, NMDA-independent LTP has been
demonstrated by a number of investigators (see [72, 79]
for reviews). Additional studies have revealed that activation
of calpain [80–82], protein kinase C [83, 84], calcium-
calmodulin kinase type 2 [85, 86], and the release of Ca2+
from intracellular storage pools [87] also contribute to
hippocampal LTP. Further, there is evidence that LTP may
be dependent upon the release of suﬃcient GABA to activate
GABAB autoreceptors, which in turn prevents further GABA
release [88].Teyleretal.[89–92]haveproposedthatthereare
two forms of LTP. One form is based on the NMDA receptor
system which can be blocked with the NMDA receptor
antagonist MK-801. The other type of LTP is dependent
upon voltage-dependent calcium channels (VDCC) and can
be blocked with the VDCC blocker verapamil. Both NMDA-
andVDCC-LTPappeartooccurduringtetanus-inducedLTP.
Further, the argument is made that a functional NMDA
system can mediate learning and memory for several hours;
however, the activation of the VDCC-LTP system is required
for longer periods, that is, over several days.
MMP-9 and -2 have been implicated in LTP. Hippocam-
pal slice cultures taken from MMP-9 knockout mice revealed
impaired LTP which was restored with the addition of
recombinant MMP-9 [93]. Hippocampal MMP-9 is up-
regulatedandactivatedduringthemaintenancephaseofLTP
[94]. This potential could be inhibited by blocking integrin
signaling, suggesting that MMP-9 may mediate neural plas-
ticityviaintegrins[93].UsingprefrontalcortexslicesOkulski
and colleagues [29] reported that MMP-9 is necessary for
late stage LTP, and treatment with an MMP-9 inhibitor
prevented the formation of late-stage LTP. Further, Wang et
al. [95] found that spine enlargement during hippocampal
LTP is dependent upon MMP-9 and protein synthesis.
If either protein synthesis or MMP activity was blocked,
spine enlargement was inhibited. These results generally
conﬁrm an earlier report by Reeves et al. [96] describing
unilateral lesions of the entorhinal cortex in rats followed
by intracerebroventricular (icv) infusion of a general MMP
inhibitor (FN-439). After 7 days control rats that received
icv saline following lesioning revealed normal collateral
sprouting, synaptogenesis, and LTP. In contrast, those rats
that received icv FN-439 lost the capacity to exhibit LTP
and evidenced considerable cellular debris, suggesting that
MMPsareanecessarycomponentofthedeaﬀerentiationand
sprouting phenomena. Our laboratory has also measured
impaired paired-pulse facilitation, induction and stability of
LTP, and long-term depression (LTD) in hippocampal slices
treated with FN-439 [97, 98].
A recent investigation is of particular importance to this
discussion. Bozdagi et al. [94] utilized anesthetized young
adult rats to study the contribution of MMP-9 to synaptic
plasticity.TheSchaﬀercollateralcommissuralprojectionwas
stimulated while ﬁeld EPSPs were recorded from area CA1
striatum radiatum. Pressure infusion of recombinant-active
MMP-9 (rMMP-9) into the CA1 area produced a slow,
but progressive potentiation reaching maximum by 90–120
minutespost-administrationandremainedelevateduntilthe
experimentendedat180minutes.Itwasdeterminedthatthis
enhancement in synaptic potentiation was not presynaptic,
and once maximum potentiation to MMP-9 was achieved,
the application of tetanic stimulation failed to further
increase potentiation. The authors interpreted these results
to indicate that tetanic stimulation, and rMMP-9 activation,
share a common cellular mechanism. The intrahippocampal
infusion of an MMP-2 and -9 inhibitor followed by titanic
stimulation resulted in a strong potentiation comparableNeural Plasticity 5
to control LTP. However, following the ﬁrst 30 minutes
this potentiation slowly faded to baseline. Intrahippocam-
pal infusion of an “MMP-9-speciﬁc proteolytic function-
blocking antibody” resulted in a very similar pattern. It
was further determined that titanic stimulation resulted
in elevated MMP-9 protein levels in the CA1 area. Thus,
these results indicate that MMP-9 mediated extracellular
proteolysis is involved in the phenomenon of LTP in normal
young adult animals.
Taken together, these ﬁndings support an important role
for MMPs in LTP and indicate that in particular MMP-9 is
a necessary component in supporting the stabilization of the
maintenance phase of LTP.
3.2. Habituation. Nonassociative learning includes the phe-
nomena of habituation, dishabituation, and sensitization
and is considered to be the simplest form of learning.
Of these habituation is the most frequently studied and
refers to a decrease in responding (as related to frequency,
magnitude, or intensity) to a stimulus repeatedly presented,
or presented for a prolonged period of time [99–101].
Habituation has been documented across many species
and response systems ranging from the gill-withdrawal
reﬂex in Aplysia [102] and tap withdrawal or chemotaxic
response in the nematode Caenorhabditis elegans [103], to
acoustic startle response in rats and mice [104], schedules
of reinforcement in operant conditioning [105, 106]a n d
feedinginhumans[107].Althoughtheneuralmechanism(s)
underlying habituation has not been identiﬁed, the hip-
pocampus has been implicated in the control of inhibitory
processes, particularly habituation [108–110]. In support
of this notion bilateral hippocampectomy in rats has been
shown to interfere with habituation to familiar objects in
an open ﬁeld object recognition task [111, 112], severely
impair the acquisition and recall of platform location in
the Morris water maze task [113], but failed to alter the
habituatory pattern or rate of head-shake response (HSR)
[114]. The HSR consists of a rapid rotation of the head
about the anterior to posterior axis in response to a mild
air stimulus applied to the ear [115]. This response follows
a remarkably predictable decreasing negatively accelerated
function of stimulus frequency (Figure 2).
Our laboratory has measured HSR habituation-induced
increases in MMP-3 expression in the hippocampus, pre-
frontal, and piriform cortices, with no change in the cere-
bellum [115]. Elevations in hippocampal MMP-9 activity
werealsomeasuredinthesehabituatedanimalsaccompanied
by decreases in the prefrontal cortex. To our surprise yoked
control rats, introduced to the test environment but not HSR
habituated, also revealed intermediate elevations in MMP-
3 expression in the hippocampus and piriform cortices as
comparedwithhabituatedandhomecagecontrolrats.These
resultssuggestedthatelevationsinMMP-3couldmediatethe
changesinneuralplasticitythatmayaccompanyhabituation;
however the introduction of the animal into a new environ-
ment also appeared to elevate MMP-3 expression in these
samebrainstructures,buttoalesserextent.Thesechangesin
MMP-3 levels were evidenced by the yoked control animals
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Figure 2: Mean (± SEM) group changes in head-shake responses
(HSR) per three-trial blocks during sessions I and II. These sessions
were separated by 5 minutes, 2, 6, or 24 hours, respectively. There
were no diﬀerences among these groups comparing the ﬁrst trial
blocks of Session I. Each group signiﬁcantly diﬀered from the
others comparing the ﬁrst trail blocks of Session II. Speciﬁcally,
the 5 minute ISI group indicated very little spontaneous recovery
suggesting excellent memory retention of the habituatory response.
The 2 and 6 hours ISI groups showed increments in spontaneous
recovery and thus some loss of memory retention, while the 24-
hour ISI group revealed 95% spontaneous recovery suggesting
nearly complete loss of memory retention for habituation of the
HSR, ∗P<. 05, modiﬁed from Wright et al. [115].
despite eﬀorts to minimize environmental cues (i.e., low
ambient light and suppressed extraneous noise in a room
painted black). Given that acquisition of such spatial cues is
mediated by hippocampal and prefrontal cortices (see [116,
117] for reviews) it is perhaps not surprising that elevations
in MMP expression were measured in these structures.
However, habituation to irrelevant spatial cues is clearly an
important aspect of successful performance in an associative
learning task, and this too appears to be a function of the
hippocampus and prefrontal cortex [108–110].
3.3. Associative Learning. As outlined above it is assumed
that neural activity-dependent changes in synaptic adhesion
underlie the morphological and functional plasticity of those
synapses involved in learning and memory [118, 119].
Alterations in intrasynaptic ECM molecules, as inﬂuenced
by CAMs, are presumed to be responsible for alterations in
the synaptic architecture, and thus the eﬃciency of synaptic
transmission [120–124], and to underlie neural plasticity
and memory consolidation [125, 126]. Given that MMPs are
responsible for degrading and restructuring the ECM it is
not surprising that they have been investigated with regard
to seizure, associative learning, and memory. MMP-9 levels
and activity increase in the hippocampus following kainic
acid-andbicuculline-inducedseizures[63,127–129]andar e6 Neural Plasticity
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Figure 3: Mean (± SEM) group changes in number of HSR per 3-trial blocks during sessions I and II of habituation trials separated by a
24 hours ISI. (a) These independent groups of rats were bilaterally infused into the dorsal hippocampus with artiﬁcial cerebrospinal ﬂuid
(aCSF, 2.5μL each side), a low dose of FN-439 of 25μg (Low FN-439), or a high dose of FN-439 of 50μg (High FN-439) at 5 and 60 minutes
following the termination of session I. All groups received a contingent signaling tone immediately prior to the air stimulus on each trial.
TherewerenodiﬀerencesamongthegroupsconcerningthepatternofhabituationduringsessionI.Therewerediﬀerencesamongthegroups
during the ﬁrst trial block of session II with the high FN-439 group revealing a signiﬁcantly higher level of spontaneous recovery (poorer
memory retention) as compared with the other two groups that did not diﬀer. (b) Members of these two groups were bilaterally infused
with aCSF or MMP-3 inhibitor (MMP-3i, 50μgi n2 . 5μL aCSF) into the dorsal hippocampus at 5 and 60 minutes following the conclusion
of session I. Members of both groups received contingent tone immediately pior to the application of the air stimulus on each trial. The
two groups did not diﬀer regarding pattern of habituation during session I; however, members of the MMP-3 inhibitor group revealed a
signiﬁcantly higher level of spontaneous recovery (poorer memory retention) as compared with the aCSF group during the ﬁrst trial block
of session II, ∗P<. 0001, modiﬁed from Wiediger and Wright [136].
correlated with subsequent synapse formation. In addition,
MMPs are known to play an important role in synaptic
remodeling that results from hippocampal diﬀerentiation
[130, 131].
OurlaboratorynotedMMP-9elevationsintheprefrontal
and piriform cortices of rats tested in an object recognition
task, and in the prefrontal and hippocampal cortices of rats
that were successful in solving the Morris water maze task
[23]. These results were conﬁrmed and extended by Meighan
et al. [98] who noted signiﬁcant elevations in hippocampal
MMP-3 and -9 during acquisition of the Morris water
maze task. The inhibition of MMP activity with MMP-
3 and -9 antisense oligonucleotides, or FN-439 prevented
successfulperformanceofthistask.Theabilitytoacquirethis
spatial memory task was shown to result in the diﬀerential
stability of cortactin, an actin-binding protein involved in
regulating the dendritic cytoskeleton and synaptic eﬃciency.
Nagy et al. [132] have reported signiﬁcant elevations in
hippocampal MMP-9 levels following inhibition avoidance
learning in rats, peaking at 12–24 hours following training
and declining to baseline by three days post-training.
Intrahippocampal infusion of a MMP-2 and -9 inhibitor 3.5
hours following inhibitory avoidance training signiﬁcantly
diminished subsequent recall. Similar results were obtained
with the bilateral intra-hippocampal infusion of FN-439
resulting in signiﬁcant interference with the acquisition
of the Morris water maze task [133]. Olson et al. [134]
havemeasuredelevationsinhippocampalMMP-3beginning
1 hour following passive avoidance training in rats and
returning to baselevel by 24 hours post-training. When a
speciﬁcMMP-3inhibitorwasicvinfused20minutespriorto,
and 50 minutes following training, dose-dependent learning
deﬁcits were seen. Finally, Brown et al. [135] found that icv
infusion of FN-439 30 minutes prior to fear conditioning
(tone-foot shock paired association), or 30 minutes prior to
a single retest session 24 hours after conditioning, disrupted
successful memory retrieval of the conditioned freezing-in-
place response. This reduction in freezing was not due to a
decrease in overall anxiety level given that FN-439 failed to
inﬂuence normal elevated plus-maze task performance.
Recently, we combined HSR habituation with a classical
conditioning paradigm to evaluate the importance of a
signaling cue that immediately preceded the onset of the
a i rs t i m u l u st ot h ee a r[ 136]. Bilateral dorsal hippocampus
injections of FN-439, or a speciﬁc MMP-3 inhibitor, inter-
fered with acquisition of the association between a signaling
tone and the HSR such that only a very weak association was
present when retested 24 hours later (Figure 3). These results
suggest that a functioning dorsal hippocampus is critical to
storageofthisclassicallyconditionedassociationbetweentheNeural Plasticity 7
signaling cue and the air stimulus to the ear that initiates the
HSR. Speciﬁcally, interference with activation of MMP-3 in
the dorsal hippocampus appears to signiﬁcantly disrupt the
acquisition and memory storage of this association.
There is accumulating evidence to support the notion
that MMP-3 and -9 are of signiﬁcant importance in the
acquisition of several forms of associative learning including
object recognition, spatial, passive avoidance and classical
conditioning.
4. AddictiveDrugs
Learning and memory appear to be intimately involved in
the process of drug addiction [137–141]. Changes in neuron
morphology during and following drug addiction have been
reported [142–145]. To date only a few studies have focused
on changes in ECM molecules accompanying drug addiction
(see [146, 147] for reviews). Brown and colleagues [135]
reported that icv injection of FN-439 suppressed acquisition
of cocaine-induced conditioned place preference (CPP) in
rats. This general MMP inhibitor also attenuated cocaine-
primed reinstatement in extinguished animals. In agreement
with these ﬁndings Mash et al. [148]h a v ec o m p a r e dp a t t e r n s
of gene expression in human chronic cocaine abusers with
drug-free control subjects. The cocaine abusers revealed 151
gene transcripts up-regulated and 91 down-regulated. One
up-regulated transcript was RECK, a membrane-anchored
MMP inhibitor associated with angiogenesis and ECM
integrity. Signiﬁcant decreases in hippocampal MMP-9 pro-
tein levels were also measured in the cocaine abusers. These
investigators speculated that hippocampal ECM remodeling
(or lack of) may characterize chronic cocaine abuse and
contribute to relapse. These researchers are the ﬁrst to
indicate an important role for MMPs in the acquisition
and reconsolidation of memories associated with cocaine
addiction. Brown et al. [135] have also suggested that MMP
inhibitorsmaybeusefulindisruptinganestablishedcocaine-
induced memory in that memory reconsolidation could be
suppressed. Most recently these investigators have shown
that MMP-9 increased in the prefrontal cortex following
cocaine reinstatement of CPP in rats [149].
Mizoguchi et al. [150, 151] used an MMP-2 and -
9 inhibitor to prevent methamphetamine-induced CPP in
mice. They further showed that MMP-2 and -9 deﬁcient
mice displayed attenuated sensitization and cocaine CPP
when methamphetamine-primed. Liu et al. [152]h a v e
further reported that with both stimulant or toxic doses
of methamphetamine brain MMP-9 gene expression was
up-regulated within 5 minutes. By 24 hours MMP-9 up-
regulation had returned to control levels in the stimulant
treated mice but was still elevated in those mice that received
the higher toxic dose. MMP-9 knockout mice were capa-
ble of evidencing methamphetamine-induced neurotoxicity
suggesting that MMP-9 expression is not a contributor to the
neurotoxicity.
Some years ago Sillanaukee et al. [153]c o m p a r e ds e r u m
M M P - 9l e v e l so fm i d d l ea g em a l ea l c o h o l i c s( >1000g/week)
and male social drinkers (<2 0 0 g / w e e k )i na na t t e m p tt o
identify a mechanism underlying alcohol-induced cardio-
vascular disease. MMP-9 concentrations were signiﬁcantly
higher in the alcoholic group as compared with social
drinkers. These results are important given recent evidence
that alcohol treatment not only increased MMP-1, -2, and -
9 activity and decreased TIMP-1 and -2, but also increased
blood-brain barrier permeability [154]. These researchers
suggested that the elevations in MMP could be responsible
for basement membrane degradation leading to a reduc-
tion in barrier tightness. Our laboratory has established a
relationship between ethanol-induced impairment of spatial
memory (Morris water maze task) and decreased MMP-9
levels in the hippocampus and prefrontal cortex [155]i n
rats tested over a period of several days. Presumably these
ethanol-induced declines in active MMP-9 levels attenuated
the formation of new neural pathways thus interfering with
memory consolidation.
These ﬁndings suggest that deviations in brain MMP
activity may be prerequisite to reconﬁguration of the ECM
molecules that permit synaptic reconﬁguration and the
establishment of new memories. This appears to hold for
memories associated with, and in support of, addictive drugs
as well.
5. Conclusion
Thisreviewbringstogetheravailableinformationconcerning
the hypothesis that it is the interaction among ECM
molecules, MMPs, CAMs, and TIMPs that permits the
formation of new neural pathways in the brain. These
new synaptic connections are stimulated by experiences in
environmentsthatresultinlearningacquisitionandmemory
consolidation. Thus, memory consolidation is presumably
mediated and made possible by the process of neural
plasticity. However, a number of research questions must
be addressed in order for this important area of research to
move forward. (1) There is accumulating evidence that LTP
triggers the synthesis, release, and activation of proteases,
particularly MMPs. Much of this work has been completed
in the hippocampus, dentate gyrus, and entorhinal cortex.
Other brain areas must be examined. Also, the majority
of studies have utilized the general MMP inhibitor, FN-
439. More speciﬁc MMP inhibitors are now available and
should be employed. (2) Once these synaptic connections
are formed how are they maintained and protected from
degradation? (3) Following memory consolidation how is
this information retrieved without re-triggering synaptic
reconﬁguration? (4) With the retrieval of information how
is the process of short-term memory acquisition terminated
such that the new memory trace can be reconsolidated
and placed back into a ﬁxed conﬁguration? (5) Important
environmental information appears to be temporarily stored
in the hippocampus and then transferred to other brain
structures for long-term storage. How does this occur? Are
the same molecules (ECM, CAMs, MMPs, TIMPs) involved
in this transfer process? Does the ultimate storage location
depend upon the type of learning and/or the sensory systems
involved? (6) What is the role of neural plasticity in drug8 Neural Plasticity
addiction? There are many unanswered questions regarding
the inﬂuence of drugs on LTP stimulated MMP release
and activation, and equally important the role of TIMPs
during LTP. Beyond these issues there are additional ques-
tions regarding the inﬂuence of drug addiction on neural
plasticity and memory consolidation in the hippocampus,
neocortex, and amygdala as well as other brain structures.
Comprehensive answers to these and related questions will
require signiﬁcant eﬀort but once available should provide
valuable clues concerning the basic processes of memory
formation and will contribute to our understanding of how
failures in memory acquisition, storage, and retrieval occur.
Hopefully, this insight will result in clinical interventions
designed to correct these deﬁciencies in dysfunctional mem-
ory disease states and also provide new treatment strategies
for preventing drug addiction and relapse.
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